YuX-M, SchneiderDF, LeversonG, ChenH, SippelRS. 2013. Follicular variant of papillary thyroid carcinoma is a unique clinical entity: a population-based study of 10,740 cases. Thyroid, 23:1263–1268.
2.
DanielsGH. 2011. What if many follicular variant papillary thyroid carcinomas are not malignant? A review of follicular variant papillary thyroid carcinoma and a proposal for a new classification. Endocr Pract, 17:765–787.
3.
LinHW, BhattacharyyaN. 2010. Clinical behavior of follicular variant of papillary thyroid carcinoma presentation and survival. Laryngoscope, 120:712–716.
4.
Aschebrook-KilfoyB, GroganRH, WardMH, KaplanE, DevesaSS. 2013. Follicular thyroid cancer incidence patterns in the United States, 1980–2009. Thyroid, 23:1015–1021.
5.
EnglumBR, PuraJ, ReedSD, RomanSA, SosaJA, ScheriRP. 2015. A bedside risk calculator to preoperatively distinguish follicular thyroid carcinoma from follicular variant of papillary thyroid carcinoma. World J Surg, 39:2928–2934.
6.
LloydRV, EricksonLA, CaseyMB, LamKY, LohseCM, AsaSL, ChanJKC, DeLellisRA, HarachHR, KakudoK, LiVolsiVA, RosaiJ, SeboTJ, Sobrinho-SimoesM, WenigBM, LaeME. 2004. Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma. Am J Surg Pathol, 28:1336–1340.
7.
ElsheikhTM, AsaSL, ChanJKC, DeLellisRA, HeffessCS, LiVolsiVA, WenigBM. 2008. Inter-observer and intra-observer variation among experts in the diagnosis of thyroid follicular lesions with borderline nuclear features of papillary carcinoma. Am J Clin Pathol, 130:736–744.
8.
LiuJ, SinghB, TalliniG, CarlsonDL, KatabiN, ShahaA, TuttleRM, GhosseinRA. 2006. Follicular variant of papillary thyroid carcinoma: a clinicopathologic study of a problematic entity. Cancer, 107:1255–1644.
9.
Handkiewicz-JunakD, CzarnieckaA, JarzabB. 2010. Molecular prognostic markers in papillary and follicular thyroid cancer: current status and future directions. Mol Cell Endocrinol, 322:8–28.
10.
RiveraM, Ricarte-FilhoJ, KnaufJ, ShahaA, TuttleM, FaginJA, GhosseinRA. 2010. Molecular genotyping of papillary thyroid carcinoma follicular variant according to its histological subtypes (encapsulated vs infiltrative) reveals distinct BRAF and RAS mutation patterns. Mod Pathol, 23:1191–200.
11.
Cancer Genome Atlas Research Network. 2014. Integrated genomic characterization of papillary thyroid carcinoma. Cell, 159:676–690.
12.
NikiforovYE, SeethalaRR, TalliniG, BalochZW, BasoloF, ThompsonLD, BarlettaJA, WenigBM, Al GhuzlanA, KakudoK, GiordanoTJ, AlvesVA, KhanafsharE, AsaSL, El-NaggarAK, GoodingWE, HodakSP, LloydRV, MaytalG, MeteO, NikiforovaMN, NoséV, PapottiM, PollerDN, SadowPM, TischlerAS, TuttleRM, WallKB, LiVolsiVA, RandolphGW, GhosseinRA. 2016. Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: a paradigm shift to reduce overtreatment of indolent tumors. JAMA Oncol, 2016Apr14. [Epub ahead of print]; DOI: 10.1001/jamaoncol.2016.0386.
13.
BalochZW, LiVolsiVA. 2002. Follicular-patterned lesions of the thyroid. The bane of the pathologist. Am J Clin Pathol, 117:143–150.
14.
WidderS, GuggisbergK, KhalilM, PasiekaJL. 2008. A pathologic re-review of follicular thyroid neoplasms: the impact of changing the threshold for the diagnosis of the follicular variant of papillary thyroid carcinoma. Surgery, 144:80–85.
15.
NikiforovYE, CartySE, ChioseaSI, CoyneC, DuvvuriU, FerrisRL, GoodingWE, HodakSP, LeBeauSO, OhoriNP, SeethalaRR, TublinME, YipL, NikiforovaMN. 2014. Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next-generation sequencing assay. Cancer, 120:3627–3634.
16.
NikiforovYE, CartySE, ChioseaSI, CoyneC, DuvvuriU, FerrisRL, GoodingWE, LeBeauSO, OhoriNP, SeethalaRR, TublinME, YipL, NikiforovaMN. 2015. Impact of the multi-gene ThyroSeq next-generation sequencing assay on cancer diagnosis in thyroid nodules with atypia of undetermined significance/follicular lesion of undetermined significance cytology. Thyroid, 25:1217–1223.
17.
FaquinWC, WongLQ, AfroghehAH, AliSZ, BishopJA, BongiovanniM, PusztaszeriMP, VandenBusscheCJ, GourmaudJ, VaickusLJ, BalochZW. 2016. Impact of reclassifying noninvasive follicular variant of papillary thyroid carcinoma on the risk of malignancy in The Bethesda System for Reporting Thyroid Cytopathology. Cancer Cytopathol, 124:181–187.
18.
McFaddenDG, Dias-SantagataD, SadowPM, LynchKD, LubitzC, DonovanSE, ZhengZ, LeL, IafrateA, DanielsGH. 2014. Identification of oncogenic mutations and gene fusions in the follicular variant of papillary thyroid carcinoma. J Clin Endocrinol Metab, 99:E2457–2462.
19.
ChaiYJ, SuhH, YiJW, YuHW, LeeJH, KimSJ, WonJK, LeeKE. 2016. Factors associated with the sensitivity of fine-needle aspiration cytology for the diagnosis of follicular variant papillary thyroid carcinoma. Head Neck, 38:E1467–1471.
20.
ZhuZ, GandhiM, NikiforovaMN, FischerAD, NikiforovYE. 2003. Molecular profile and clinical-pathologic features of the follicular variant of papillary thyroid carcinoma (an unusually high prevalence of RAS mutations). Am J Clin Pathol, 120:71–77.
21.
van HeerdenJA, HayID, GoellnerJR. 1992. Follicular thyroid carcinoma with capsular invasion alone: a nonthreatening malignancy. Surgery, 112:1130–1136.
22.
HaugenBR, AlexanderEK, BibleKC, DohertyG, MandelSJ, NikiforovYE, PaciniF, RandolphG, SawkaA, SchlumbergerM, SchuffKG, ShermanSI, SosaJA, StewardD, TuttleRM, WartofskyL. 2016. American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer. Thyroid, 26:1–133.
23.
XuB, WangL, TuttleRM, GanlyI, GhosseinR. 2015. Prognostic impact of extent of vascular invasion in low-grade encapsulated follicular cell-derived thyroid carcinomas: a clinicopathologic study of 276 cases. Hum Pathol, 46:1789–1798.
24.
NikiforovaMN, LynchRA, BiddingerPW, AlexanderEK, DornGW2nd, TalliniG, KrollTG, NikiforovYE. 2003. RAS point mutations and PAX8-PPARgamma rearrangement in thyroid tumors: evidence of distinct molecular pathways in thyroid follicular carcinoma. J Clin Endocrinol Metab, 88:2318–2326.
